These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
138 related items for PubMed ID: 2508505
21. [Bronchopulmonary infection due to Branhamella catarrhalis in patients with obstructive lung disease]. Wu LB. Zhonghua Jie He He Hu Xi Za Zhi; 1990 Dec; 13(6):328-30, 378. PubMed ID: 2128216 [Abstract] [Full Text] [Related]
22. Antibiotic-sensitivity of Moraxella catarrhalis isolated from clinical materials in 1997-1998. Mikucka A, Janicka G, Krawiecka D, Kochanowska J. Med Sci Monit; 2000 Dec; 6(2):300-4. PubMed ID: 11208326 [Abstract] [Full Text] [Related]
23. Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the SENTRY Antimicrobial Surveillance Program, 1997-1999. Hoban DJ, Doern GV, Fluit AC, Roussel-Delvallez M, Jones RN. Clin Infect Dis; 2001 May 15; 32 Suppl 2():S81-93. PubMed ID: 11320449 [Abstract] [Full Text] [Related]
24. Determination of the antimicrobial susceptibilities of Canadian isolates of Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis. Canadian Antimicrobial Study Group. Blondeau JM, Suter M, Borsos S. J Antimicrob Chemother; 1999 Mar 15; 43 Suppl A():25-30. PubMed ID: 10225568 [Abstract] [Full Text] [Related]
25. Bronchopulmonary infection due to Moraxella (Branhamella) catarrhalis at a specialist hospital in Saudi Arabia. Ahmad S. J Commun Dis; 1998 Dec 15; 30(4):233-6. PubMed ID: 10810561 [Abstract] [Full Text] [Related]
28. Emergence of resistant bacterial strains during treatment of infections in the respiratory tract. Kosmidis J, Koratzanis G. Scand J Infect Dis Suppl; 1986 Dec 15; 49():135-9. PubMed ID: 3103208 [Abstract] [Full Text] [Related]
30. Lung infections. 2. Branhamella catarrhalis: epidemiological and clinical aspects of a human respiratory tract pathogen. Murphy TF. Thorax; 1998 Feb 15; 53(2):124-8. PubMed ID: 9624298 [No Abstract] [Full Text] [Related]
31. [In vitro activity of 3 fluoroquinolones on Branhamella catarrhalis]. Suermondt G, Denamur E, Laurans G, Orfila J. Pathol Biol (Paris); 1988 Jun 15; 36(5 Pt 2):647-50. PubMed ID: 3141885 [Abstract] [Full Text] [Related]
32. [Nosopharyngeal microflora in ambulatory treated children and adults with upper respiratory tract infections]. Zientara M, Rudy M, Nowakowska M, Martirosian G. Med Dosw Mikrobiol; 2006 Jun 15; 58(3):239-45. PubMed ID: 17340999 [Abstract] [Full Text] [Related]
33. [Respiratory tract infections caused by Branhamella catarrhalis in outpatients with pneumoconiosis]. Ide M, Takasugi M, Yoshida S, Mori K, Mochinaga S, Yoshida T, Matsumoto K. Kansenshogaku Zasshi; 1989 Apr 15; 63(4):363-8. PubMed ID: 2506294 [Abstract] [Full Text] [Related]
34. [Clinical, diagnostic and therapeutic aspects of Moraxella catarrhalis infections]. Bourgeois F, Lambert-Zechovsky N, Bingen E. Pathol Biol (Paris); 1993 Jun 15; 41(6):555-61. PubMed ID: 8247636 [Abstract] [Full Text] [Related]
35. Emergence of antibiotic resistance in upper and lower respiratory tract infections. Jacobs MR. Am J Manag Care; 1999 Aug 15; 5(11 Suppl):S651-61. PubMed ID: 10558123 [Abstract] [Full Text] [Related]
36. Respiratory tract infection: epidemiology and surveillance. Jacobs MR. J Chemother; 1997 May 15; 9 Suppl 3():10-7. PubMed ID: 9248976 [Abstract] [Full Text] [Related]
38. Branhamella catarrhalis as a lower respiratory tract pathogen in patients with chronic lung disease. Nicotra B, Rivera M, Luman JI, Wallace RJ. Arch Intern Med; 1986 May 15; 146(5):890-3. PubMed ID: 3963981 [Abstract] [Full Text] [Related]
39. The role of Branhamella catarrhalis in the "bloody-nose syndrome" of cynomolgus macaques. VandeWoude SJ, Luzarraga MB. Lab Anim Sci; 1991 Oct 15; 41(5):401-6. PubMed ID: 1666136 [Abstract] [Full Text] [Related]